Now accepting new patients in River Oaks, Houston. Request your assessment →
That doesn't have to be the end of it.
Post-menopausal changes, postpartum shifts, and reduced arousal response are biological — and addressable. This program works at the tissue and vascular level, supporting the conditions under which your body can restore what has been lost.
Changes in arousal response, sensitivity, lubrication, and comfort with intercourse are not personality shifts — they are biological ones. Post-menopausal estrogen decline, postpartum tissue changes, and reduced genital vascularity all affect the physical environment in which sexual wellness exists. This program works at that environment directly. Clinical evidence on PRP for female sexual wellness is reviewed at PubMed.
Advanced regenerative biologics are delivered to specific anatomical structures — supporting angiogenesis, neurovascular communication, and tissue modulation in the areas that govern sensitivity, lubrication, and arousal response. The protocol is targeted, physician-administered, and built around what your specific biology requires.
An optional systemic biologic adjunct supports broader regenerative and inflammatory modulation — extending the biological response beyond the local treatment site. Both components are where clinically appropriate and sourced compliantly. To understand how the assessment and program structure work, see How It Works.
Arousal Response & Sensitivity
Regenerative biologics support genital vascularity and neurovascular signaling — the biological drivers of arousal response and clitoral sensitivity that decline with hormonal and tissue changes.
Lubrication & Tissue Health
Tissue atrophy and reduced mucosal health affect comfort, lubrication, and elasticity. The program supports the local tissue environment — improving the conditions that make intimacy comfortable and natural.
Post-Menopausal & Postpartum Changes
Hormonal shifts and tissue changes associated with menopause and postpartum recovery respond to regenerative biological intervention in ways that hormonal therapy alone may not fully address.
Understanding Stem Cells & Exosomes in Sexual Wellness
The biologics used in this program — exosome-derived preparations and MSC (mesenchymal stem cell) derived growth factors — work at the tissue level to restore vascular responsiveness, mucosal health, and neurovascular signaling. These are not cosmetic applications. They are cellular interventions that address the biological conditions governing sexual function and comfort. All biologics are sourced from FDA-registered laboratories and administered under physician supervision.
The regulatory reality most Valerians are unaware of: the FDA approves and regulates the laboratories that produce these biologics — not the specific clinical protocols physicians apply them in. That is the same framework governing most of medicine. What determines legality and safety is compliant sourcing from an FDA-registered lab and physician supervision throughout. Both are absolute requirements at Valere.
The complete guide to stem cells in regenerative medicine → How stem cells support sexual wellness specifically →Your physician reviews your history, hormonal status, current symptoms, and any prior therapies. Candidacy and contraindications — including active infections, pregnancy, or known hypersensitivity — are confirmed before any protocol is recommended.
Regenerative biologics are delivered to targeted anatomical structures — peri-clitoral tissue, anterior vaginal wall, and where clinically indicated, additional sites — using a fine-gauge needle with slow, controlled technique. A topical anesthetic is applied for comfort. The procedure typically takes 20–30 minutes.
Initial treatment consists of a single session. Repeat sessions may be performed every 4–6 weeks as clinically indicated, with a typical course of 1–3 sessions. Re-evaluation occurs at 4–6 weeks to assess response and refine the program.
Early changes in sensitivity and response may be noticed within 2–4 weeks, with continued improvement up to 8–12 weeks. Avoid vaginal intercourse for 48–72 hours and intravaginal products for 5–7 days post-session. Mild swelling or bruising is normal and resolves quickly.
"These are off-label biologic products intended to support tissue signaling and wellness. They are not FDA-approved for the diagnosis, treatment, or prevention of disease. Outcomes are not guaranteed and vary by individual."
Your physician will provide a clear, honest assessment of what this program can realistically achieve for your specific biology.
Women who come to this program have often been told these changes are expected — a natural part of aging, something to manage rather than address. Valere does not accept that framing. The biology is addressable. The program is built around doing exactly that. Where hormonal health is contributing, see Women's Hormonal Health — frequently addressed within the same program.
Hormonal therapy addresses systemic levels. This program works locally — delivering regenerative biologics to the specific tissues responsible for sensitivity, arousal, and comfort. The two are not mutually exclusive. At Valere, both are addressed where indicated.
Candidacy is confirmed at assessment — not assumed from a symptom checklist. Contraindications are reviewed, your history is understood, and the protocol is built around what your specific biology requires. Not a standard intervention applied broadly.
Sexual wellness is connected to hormonal health, pelvic biology, and systemic wellbeing. Where those variables intersect with what you are experiencing, they are addressed as part of the same physician-guided plan — not siloed into separate referrals.
Private suite. By appointment only. An environment that reflects the sensitivity of the conversation — and the seriousness with which Valere approaches it.
Good candidates include adult women experiencing reduced genital sensitivity or arousal response, decreased lubrication, discomfort with intercourse related to tissue atrophy or reduced vascularity, post-menopausal or postpartum sexual changes, or reduced response to hormonal or non-hormonal therapies. Active genital infection, pregnancy, breastfeeding, known gynecologic malignancy, or known hypersensitivity are contraindications. Candidacy is confirmed at your assessment.
Hormone therapy addresses systemic hormonal levels and can improve many menopausal symptoms — but it does not directly restore the vascular and tissue health of genital structures. This program works locally, delivering regenerative biologics to the specific tissues responsible for sensitivity, arousal response, and lubrication. For Valerians already on hormonal therapy with incomplete results, this program addresses the biological layer that hormones alone may not fully reach. See Women's Hormonal Health for the full hormonal program. Clinical evidence reviewed at PubMed.
A topical anesthetic is applied before the procedure, and the delivery uses a fine-gauge needle with slow, controlled technique. Most Valerians report minimal discomfort during the session. Mild swelling or bruising in the treatment area is expected and resolves within a few days. You should avoid vaginal intercourse for 48–72 hours and intravaginal products for 5–7 days following each session.
Early changes in sensitivity and arousal response may be noticed within 2–4 weeks of the first session, with continued improvement up to 8–12 weeks as the tissue and vascular environment responds. Most Valerians undergo 1–3 sessions in total. Re-evaluation at 4–6 weeks determines whether additional sessions are warranted and how the program should be refined. For Valerians exploring how this integrates with their broader health program, see How It Works.
Your assessment is unhurried, completely discreet, and handled with the clinical seriousness this deserves. Your physician will determine candidacy and build the roadmap from there.
Reserve Your AssessmentPrivate · By appointment only · River Oaks, Houston